<DOC>
	<DOCNO>NCT01203774</DOCNO>
	<brief_summary>In study investigator would like test hypothesis diabetic patient discharge hospital , SoloSTAR Glargine insulin superior syringe-injected Glargine term diabetes control , compliance , patient satisfaction preference . The investigator test hypothesis randomize , crossover trial .</brief_summary>
	<brief_title>Comparison SoloSTAR With Syringe-administered Glargine Insulin Diabetic Patients From Hospital</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>All patient type 1 2 diabetes discharge hospital recommendation take Glargine Patients unwilling participate patient incapable comply study regimen , patient alcohol drug addiction problem patient severe mental illness</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetes</keyword>
</DOC>